Delivery Order SPE2DB20D1109-SPE2DB24FP03H
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,973.54 firm-fixed-price contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a completion date of January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. The contract has a ceiling value of $11,867.38 and a period of performance through April 17, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used in the treatment of diabetes. The contract has a ceiling value of $5,805.60 and a completion date of January 30, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a ceiling value of $14,715.17 and an ultimate completion date of November 24, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen also holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order with a firm fixed price contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $10,631.64 and an ultimate completion date of August 17, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has a ceiling value of $4,446.68 and an ultimate completion date of October 5, 2023. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,402.24, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $5,885.58. The contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to manage diabetes. The delivery order has a firm fixed price and an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The $26,756.12 firm fixed price contract has a completion date of July 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract, valued at $10,948.23, has a firm fixed price and is set to expire on November 7, 2023. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FP03HDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used for diabetes management. The contract has a ceiling value of $1,741.68 and an ultimate completion date of April 23, 2024. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare needs globally. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 4/22/24 |